Definitions
Sorry, no definitions found. You may find more data at bavituximab.
Etymologies
Sorry, no etymologies found.
Support

Help support Wordnik (and make this page ad-free) by adopting the word Bavituximab.
Examples
-
Bavituximab is a first-in-class phosphatidylserine PS-targeting monoclonal antibody that represents a new approach to treating cancer.
unknown title 2011
-
Bavituximab is a phosphatidylserine (PS)-targeting monoclonal antibody with broad therapeutic potential and also is being evaluated in randomized Phase II trials for second-line NSCLC, pancreatic cancer, and hepatitis C virus (HCV) infection, as well as in four investigator-sponsored trials (ISTs) in additional oncology indications.
unknown title 2011
-
Bavituximab is an antibody designed to bind to a type of phosphatidylserine that becomes exposed in malignant or virally infected cells, triggering the body's immune system to attack the damaged cells.
-
Bavituximab is an antibody designed to bind to a type of phosphatidylserine that becomes exposed in malignant or virally infected cells, triggering the body's immune system to attack the damaged cells.
-
Bavituximab is a first-in-class phosphatidylserine PS-targeting monoclonal antibody that represents a new approach to treating cancer.
Peregrine Initiates Randomized Phase II Trial of Bavituximab in Pancreatic Cancer - Yahoo! Finance 2011
-
Bavituximab induces immune cell-mediated destruction of cells with exposed PS and is also believed to restore the immune system's ability to recognize and respond by blocking PS-mediated immunosuppression.
-
Bavituximab is a drug currently undergoing trials for treatment of hepatitis C and the HIV virus.
-
Bavituximab is a first-in-class phosphatidylserine (PS) - targeting monoclonal antibody that represents a new approach to treating cancer.
-
Bavituximab is a novel approach to treating cancer and viral infections and has demonstrated promising interim results in ongoing Phase II clinical trials in non-small cell lung cancer (NSCLC) and advanced breast cancer.
-
Bavituximab has been shown to induce multiple immunomodulatory mechanisms, including anti-tumor effects in helping the immune system fight cancer.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.